Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide

Author： Rainsford K.  

Publisher： Springer Publishing Company

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.14, Iss.3-4, 2006-08, pp. : 120-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimer’s Disease

By McGeer P.L.  

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Meloxicam: A Cyclo-Oxygenase-2 Preferential Nonsteroidal Anti-Inflammatory Drug

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 36, Iss. 2, 1999-02 ,pp. : 115-126

Adis International

Access to resources Recommend Favorite

The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats

By Fattore L.   Melis M.   Diana M.   Fratta W.   Gessa G.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 75-77

Elsevier

Access to resources Recommend Favorite

Cyclo-Oxygenase (COX) Inhibiting Nitric Oxide Donating (CINODs) Drugs: A Review of Their Current Status

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 277-282

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Rofecoxib: A Specific Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 545-556

Adis International

Access to resources Recommend Favorite